Rameda

Rameda, an Egyptian pharmaceutical company established in 1986, is a prominent entity within the healthcare sector. The company specializes in the development and production of a comprehensive portfolio including branded generic pharmaceuticals, nutraceuticals, food supplements, and veterinary products. Rameda markets 105 distinct products across 12 therapeutic areas, underscoring its broad market coverage and commitment to diverse health needs. Recognized as one of Egypt's fastest-growing pharmaceutical players, Rameda's success is driven by its dedication to quality and continuous innovation.

Operating from a state-of-the-art production facility, Rameda houses three independent factories equipped with 20 advanced production lines. This robust manufacturing infrastructure supports its extensive product catalog and operational capacity. The company employs between 500 - 1,000 professionals, a skilled workforce dedicated to maintaining high standards in product development and manufacturing. Meet Rameda's team to discover the expertise behind its operations. Rameda extends its market reach by exporting to nine countries, signifying its growing international footprint.

With a reported revenue of $153.2M, Rameda demonstrates significant financial performance and market penetration. Its product strategy is focused on delivering high-quality, accessible pharmaceutical solutions that meet the evolving demands of healthcare professionals and patients. The company's operations cater to both B2B and B2C markets, supported by its diverse product range and stringent quality control measures. Rameda's strategic growth trajectory is fortified by ongoing innovation and a deep understanding of market dynamics within the pharmaceutical and healthcare industries.